Insurers Say Tennis Player's $9.9M Arbitration Isn't Covered
By Shawn Rice · May 5, 2021, 2:36 PM EDT
The touring company for the Women's Tennis Association can't tap into coverage for an American professional tennis player's $9.9 million arbitration over the way antidoping blood tests are administered at tournaments,...
To view the full article, register now.